Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
Molecular Cancer Research : MCR|May 4, 2016
GR and ER Coactivation Alters the Expression of Differentiation Genes and Associates with Improved ER+ Breast Cancer OutcomeDiana C West, Deng Pan, Eva Y Tonsing-Carter, et al.Cancer Discovery|November 19, 2016
Genomics of Ovarian Cancer Progression Reveals Diverse Metastatic Trajectories Including Intraepithelial Metastasis to the Fallopian TubeMark A Eckert, Shawn Pan, Kyle M Hernandez, et al.Cancer Genetics|April 18, 2025
Analytical validation of the Belay Vantage™ assay for evaluation of MGMT promoter methylation using enzymatically converted tumorDNA from cerebrospinal fluidKala F Schilter, Qian Nie, Jennifer N Adams, et al.Cancers|May 4, 2026
Clinical Validation of the Belay Ascent™ Test to Report on Chromosomal Arm-Level Aneuploidy and Gene-Level Copy Number Variants in Cerebrospinal Fluid Using Low-Pass Whole-Genome SequencingQian Nie, Kala F Schilter, Alexandra Larson, et al.Oncotarget|October 22, 2016
Integrative genomics reveals hypoxia inducible genes that are associated with a poor prognosis in neuroblastoma patientsMark A Applebaum, Aashish R Jha, Clara Kao, et al.Cold Spring Harbor Molecular Case Studies|December 5, 2023
Prostate cancer patient stratification by molecular signatures in the Veterans Precision Oncology Data CommonsKyle M Hernandez, Aarti Venkat, Danne C Elbers, et al.Breast Cancer Research : BCR|July 26, 2019
Glucocorticoid receptor modulation decreases ER-positive breast cancer cell proliferation and suppresses wild-type and mutant ER chromatin associationEva Tonsing-Carter, Kyle M Hernandez, Caroline R Kim, et al.The Journal of Molecular Diagnostics : JMD|April 25, 2025
Analytical Validation and Clinical Sensitivity of the Belay Summit Assay for the Detection of DNA Variants in Cerebrospinal Fluid of Primary and Metastatic Central Nervous System CancerQian Nie, Kala F Schilter, Kyle M Hernandez, et al.Biorxiv : the Preprint Server for Biology|July 9, 2020
Hidden genomic diversity of SARS-CoV-2: implications for qRT-PCR diagnostics and transmissionNicolae Sapoval, Medhat Mahmoud, Michael D Jochum, et al.Cancers|January 28, 2026
Analytical Validation and Clinical Sensitivity of the Belay Summit™ 2.0 Cerebrospinal Fluid Liquid Biopsy Test-An Expanded Comprehensive Genomic Profiling Platform for Central Nervous System MalignanciesSakshi Khurana, Viriya Keo, Alexandra Larson, et al.Pageof 3